AG337 inhibitor of thymidylate synthase data
AGPH (La Jolla, Calif) announced Phase I findings of efficacy in advanced refractory tumors, with reductions in
Gathering data...
AGPH (La Jolla, Calif) announced Phase I findings of efficacy in advanced refractory tumors, with reductions in